These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 24090044)
1. New cationic and neutral Ru(II)- and Os(II)-dmso carbonyl compounds. Bratsos I; Calmo S; Zangrando E; Balducci G; Alessio E Inorg Chem; 2013 Oct; 52(20):12120-30. PubMed ID: 24090044 [TBL] [Abstract][Full Text] [Related]
2. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity. Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042 [TBL] [Abstract][Full Text] [Related]
3. Electronic structures of ruthenium and osmium complexes of 9,10-phenanthrenequinone. Biswas MK; Patra SC; Maity AN; Ke SC; Adhikary ND; Ghosh P Inorg Chem; 2012 Jun; 51(12):6687-99. PubMed ID: 22663598 [TBL] [Abstract][Full Text] [Related]
5. Binding of CO and NH3 at a five-coordinate Ru(II) centre in the solid state and in solution. Ma ES; Mudalige DC; James BR Dalton Trans; 2013 Oct; 42(37):13628-34. PubMed ID: 23900615 [TBL] [Abstract][Full Text] [Related]
6. New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity. Bratsos I; Simonin C; Zangrando E; Gianferrara T; Bergamo A; Alessio E Dalton Trans; 2011 Oct; 40(37):9533-43. PubMed ID: 21853191 [TBL] [Abstract][Full Text] [Related]
7. The remarkable reactivity of high oxidation state ruthenium and osmium polypyridyl complexes. Meyer TJ; Huynh MH Inorg Chem; 2003 Dec; 42(25):8140-60. PubMed ID: 14658865 [TBL] [Abstract][Full Text] [Related]
9. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole. Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346 [TBL] [Abstract][Full Text] [Related]
10. Further Insight into the Lability of MeCN Ligands of Cytotoxic Cycloruthenated Compounds: Evidence for the Antisymbiotic Effect Trans to the Carbon Atom at the Ru Center. Barbosa AS; Werlé C; Colunga CO; Rodríguez CF; Toscano RA; Le Lagadec R; Pfeffer M Inorg Chem; 2015 Aug; 54(15):7617-26. PubMed ID: 26172528 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and structural, spectroscopic, and electrochemical characterization of new ruthenium dimethyl sulfoxide nitrosyls. Serli B; Zangrando E; Iengo E; Mestroni G; Yellowlees L; Alessio E Inorg Chem; 2002 Jul; 41(15):4033-43. PubMed ID: 12132931 [TBL] [Abstract][Full Text] [Related]
12. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action. Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368 [TBL] [Abstract][Full Text] [Related]
13. A straightforward and generalizable synthetic methodology for the synthesis of ruthenium(II) complexes with thioether ligands from either Ru(III) or Ru(0) precursors. Maiti BK; Görls H; Klobes O; Imhof W Dalton Trans; 2010 Jun; 39(24):5713-20. PubMed ID: 20495720 [TBL] [Abstract][Full Text] [Related]
14. The unprecedented bridging coordination mode of 1,1-cyclobutane dicarboxylate (mu-cbdc-O,O') stabilized by intramolecular hydrogen bonds in ruthenium(II) complexes. Bratsos I; Zangrando E; Serli B; Katsaros N; Alessio E Dalton Trans; 2005 Dec; (24):3881-5. PubMed ID: 16311642 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure, and spectroscopic, photochemical, redox, and catalytic properties of ruthenium(II) isomeric complexes containing dimethyl sulfoxide, chloro, and the dinucleating bis(2-pyridyl)pyrazole ligands. Sens C; Rodríguez M; Romero I; Llobet A; Parella T; Sullivan BP; Benet-Buchholz J Inorg Chem; 2003 Mar; 42(6):2040-8. PubMed ID: 12639139 [TBL] [Abstract][Full Text] [Related]
16. Hydrolysis and cytotoxic properties of osmium(II)/(III)-DMSO-azole complexes. Short communication. Egger A; Cebrián-Losantos B; Stepanenko IN; Krokhin AA; Eichinger R; Jakupec MA; Arion VB; Keppler BK Chem Biodivers; 2008 Aug; 5(8):1588-1593. PubMed ID: 18729098 [TBL] [Abstract][Full Text] [Related]
17. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents. Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524 [TBL] [Abstract][Full Text] [Related]
18. (15)N NMR spectroscopy unambiguously establishes the coordination mode of the diimine linker 2-(2'-pyridyl)pyrimidine-4-carboxylic acid (cppH) in Ru(ii) complexes. Battistin F; Balducci G; Demitri N; Iengo E; Milani B; Alessio E Dalton Trans; 2015 Sep; 44(35):15671-82. PubMed ID: 26251967 [TBL] [Abstract][Full Text] [Related]
19. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior. Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A. Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]